GLOBAL SINGLE CELL ANALYSIS FORECAST 2017-2025
KEY FINDINGS
The single cell analysis market is expected to grow worldwide at a CAGR of 19.72% between the forecast periods of 2017-2025. The main driving factor for this expected growth is the increased technological advancement in single cell analysis products in the recent years, the increasing number of biopharmaceutical and biotechnological companies and the increasing prevalence of infectious diseases globally.
MARKET INSIGHTS
The single cell analysis market is mainly divided into two aspects of research application and medical application. The research applications consists of various aspects like cancer market, immunology market, neurology market, and the stem cells market along with various other research application of single cell analysis in areas like developmental biology, metagenomics, drug discovery, plant biology, microbial ecology, evolution, forensics, and allele-specific gene expression and hence has an upper hand over the medical application market which is divided between circular tumor cells (CTCS) market, non-invasive prenatal diagnosis market, and in-vitro fertilization (IVF) market. In terms of techniques, micro array is currently the fastest growing market with an expected CAGR of 20.20%. With respect to the cell type the human cells market holds the largest market share in the global single cell analysis market as compared to the animal cell market. Also, thec consumables products are fast becoming the current market leaders with the fastest growing market with products like assay kits, beads, micro plates, reagents etc
REGIONAL INSIGHTS
The increasing applications of single-cell analysis in cancer research in the Northern America due to advanced technology, booming biotechnology and biopharmaceutical industries and rising prevalence of infectious diseases is estimated to get it the maximum share in the single cell market by the year 2025 closely followed by Asia-Pacific which is growing considerably fast owning to the need for stem cell therapies and a rise in lifestyle oriented diseases in the region.
COMPETITIVE INSIGHTS
The major companies competing in the single cell analysis market are Beckton Dickinson, Miltenyi Biotec, Corning Inc, Nanostring technologies Inc, Celgene corporation, Agilent technology Inc, Medtronic’s, Qiagen, GE healthcare and Stryker corporation out of which GE Healthcare has the largest market share followed by Stem cell technologies.
The single cell analysis market is expected to grow worldwide at a CAGR of 19.72% between the forecast periods of 2017-2025. The main driving factor for this expected growth is the increased technological advancement in single cell analysis products in the recent years, the increasing number of biopharmaceutical and biotechnological companies and the increasing prevalence of infectious diseases globally.
MARKET INSIGHTS
The single cell analysis market is mainly divided into two aspects of research application and medical application. The research applications consists of various aspects like cancer market, immunology market, neurology market, and the stem cells market along with various other research application of single cell analysis in areas like developmental biology, metagenomics, drug discovery, plant biology, microbial ecology, evolution, forensics, and allele-specific gene expression and hence has an upper hand over the medical application market which is divided between circular tumor cells (CTCS) market, non-invasive prenatal diagnosis market, and in-vitro fertilization (IVF) market. In terms of techniques, micro array is currently the fastest growing market with an expected CAGR of 20.20%. With respect to the cell type the human cells market holds the largest market share in the global single cell analysis market as compared to the animal cell market. Also, thec consumables products are fast becoming the current market leaders with the fastest growing market with products like assay kits, beads, micro plates, reagents etc
REGIONAL INSIGHTS
The increasing applications of single-cell analysis in cancer research in the Northern America due to advanced technology, booming biotechnology and biopharmaceutical industries and rising prevalence of infectious diseases is estimated to get it the maximum share in the single cell market by the year 2025 closely followed by Asia-Pacific which is growing considerably fast owning to the need for stem cell therapies and a rise in lifestyle oriented diseases in the region.
COMPETITIVE INSIGHTS
The major companies competing in the single cell analysis market are Beckton Dickinson, Miltenyi Biotec, Corning Inc, Nanostring technologies Inc, Celgene corporation, Agilent technology Inc, Medtronic’s, Qiagen, GE healthcare and Stryker corporation out of which GE Healthcare has the largest market share followed by Stem cell technologies.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
4. MARKET OVERVIEW
4.1. DRIVERS
4.1.1. EXPANDING TECHNOLOGICAL INNOVATIONS
4.1.2. EXPANDING OCCURRENCE OF TRANSMITTABLE INFECTIONS ACROSS THE GLOBE
4.1.3. GROWING AGED POPULACE
4.1.4. GROWING BIOPHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
4.1.5. RISING GOVERNMENT SUBSIDY FOR RESEARCH
4.2. RESTRAINTS
4.2.1. LARGE PRIMARY COST DISCOURAGING INVESTMENT
4.2.2. CONCERNS ASSOCIATED WITH INTELLECTUAL PROPERTY AND PATENTS RIGHTS
4.3. MARKET OPPORTUNITY
4.3.1. SINGLE-CELL SEQUENCING (SCS) PROCESS BEING INCREASINGLY USED IN DNA AND RNA ANALYSIS
4.3.2. DEVELOPMENT OF INNOVATIVE MODALITIES
4.3.3. INCREASING USAGE OF MICRO FLUID SINGLE CELL TECHNIQUES
4.3.4. INCREASING INVESTMENT MADE BY THE ASIAN COUNTRIES
4.3.5. ENHANCE OPPORTUNITY IN CANCER CELL RESEARCH
4.4. CHALLENGES
4.4.1. LACK OF ADEQUATE INFRASTRUCTURE
4.4.2. DELAYED ADOPTION OF SINGLE CELL TECHNOLOGY
5. MARKET SEGMENTATION
5.1. BY APPLICATION
5.1.1. MEDICAL APPLICATIONS MARKET
5.1.1.1. CIRCULAR TUMOUR CELLS (CTCS) MARKET
5.1.1.2. NON-INVASIVE PRENATAL DIAGNOSIS MARKET
5.1.1.3. IN VITRO FERTILIZATION (IVF) MARKET
5.1.2. RESEARCH APPLICATIONS MARKET
5.1.2.1. CANCER MARKET
5.1.2.2. IMMUNOLOGY MARKET
5.1.2.3. NEUROLOGY MARKET
5.1.2.4. STEM CELLS MARKET OTHER RESEARCH APPLICATIONS MARKET
5.2. BY TECHNIQUE
5.2.1. FLOW CYTOMETRY MARKET
5.2.2. MASS SPECTROMETRY MARKET
5.2.3. MICROSCOPY MARKET
5.2.3.1. NEXT-GENERATION SEQUENCING (NGS) MARKET
5.2.3.2. PCR (POLYMERASE CHAIN REACTION) MARKET
5.2.3.3. OTHER TECHNIQUES MARKET
5.3. BY CELL TYPE
5.3.1. ANIMAL CELLS MARKET
5.3.2. HUMAN CELLS MARKET
5.3.3. MICROBIAL CELLS MARKET
5.4. BY END USER
5.4.1. BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET
5.4.2. CELL BANKS AND IVF CENTERS MARKET
5.4.3. HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET
5.4.4. RESEARCH & ACADEMIC LABORATORIES MARKET
5.5. BY PRODUCT
5.5.1. CONSUMABLE MARKET
5.5.1.1. ASSAY KITS MARKET
5.5.1.2. BEADS MARKET
5.5.1.3. MICROPLATES MARKET
5.5.1.4. REAGENTS MARKET
5.5.1.5. OTHER CONSUMABLES MARKET
5.5.2. INSTRUMENT MARKET
5.5.2.1. CELL COUNTER MARKET
5.5.2.2. CELL MICROARRAYS MARKET
5.5.2.3. FLOW CYTOMETERS MARKET
5.5.2.4. HCS SYSTEMS MARKET
5.5.2.5. MICROSCOPES
5.5.2.6. OTHER INSTRUMENTS
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCT
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.4.4. APPLICATION AND EFFECTIVENESS
6.5. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. NORTH AMERICA SINGLE CELL ANALYSIS MARKET
7.1.1. UNITED STATES (U.S.) SINGLE CELL ANALYSIS MARKET
7.1.2. CANADA SINGLE CELL ANALYSIS MARKET
7.2. EUROPE SINGLE CELL ANALYSIS MARKET
7.2.1. UNITED KINGDOM (UK) SINGLE CELL ANALYSIS MARKET
7.2.2. FRANCE SINGLE CELL ANALYSIS MARKET
7.2.3. GERMANY SINGLE CELL ANALYSIS MARKET
7.2.4. SPAIN SINGLE CELL ANALYSIS MARKET
7.2.5. ITALY SINGLE CELL ANALYSIS MARKET
7.2.6. ROE SINGLE CELL ANALYSIS MARKET
7.3. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET
7.3.1. INDIA SINGLE CELL ANALYSIS MARKET
7.3.2. CHINA SINGLE CELL ANALYSIS MARKET
7.3.3. JAPAN SINGLE CELL ANALYSIS MARKET
7.3.4. AUSTRALIA SINGLE CELL ANALYSIS MARKET
7.3.5. ROAPAC SINGLE CELL ANALYSIS MARKET
7.4. REST OF THE WORLD (ROW) SINGLE CELL ANALYSIS MARKET
7.4.1. LATIN AMERICA SINGLE CELL ANALYSIS MARKET
7.4.2. MENA SINGLE CELL ANALYSIS MARKET
7.4.3. AFRICA SINGLE CELL ANALYSIS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. TOP WINNING STRATEGIES
9. COMPANY PROFILES
9.1. CORNING INC.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC ANALYSIS
9.2. CELGENE CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVE
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. ILLUMINA INC.
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVE
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. MILTENYI BIOTEC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT ANALYSIS
9.4.5. STRATEGIC ANALYSIS
9.5. NANOSTRING TECHNOLOGIESINC
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVE
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. AGILENT TECHNOLOGY INC
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVE
9.6.4. SCOT ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. GE HEALTHCARE
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. BECKMAN COULTER, INC.
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. SCOT ANALYSIS
9.8.4. STRATEGIC ANALYSIS
9.9. MEDTRONIC’S PLC
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVE
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. STRYKER CORPORATION
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.10.4. STRATEGIC ANALYSIS
9.11. THERMO FISHER SCIENTIFIC, INC.
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVE
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. QIAGEN N V
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT ANALYSIS
9.12.4. STRATEGIC ANALYSIS
9.13. BECKTON DICKINSON AND COMPANY
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. SCOT ANALYSIS
9.13.4. STRATEGIC ANALYSIS
9.14. STEMCELL TECHNOLOGIES
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. STRATEGIC INITIATIVES
9.14.4. SCOT ANALYSIS
9.14.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 GLOBAL SINGLE ANALYSIS MARKET BY GEOGRAPHY 2014-2022($ MILLION)
TABLE 2 GLOBAL SUMMARY OF AIDS EPIDEMIC 2016
TABLE 3 GLOBAL SINGLE CELL ANALYSIS MARKET BY APPLICATION 2017-2025($ MILLION)
TABLE 4 GLOBAL SINGLE CELL ANALYSIS MARKET BY MEDICAL APPLICATIONS 2017-2025($ MILLION)
TABLE 5 GLOBAL CTCS MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 6 GLOBAL NIPT MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 7 GLOBAL IVF MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 8 GLOBAL SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS, BY REGION 2017-2025($ MILLION)
TABLE 9 GLOBAL SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS, BY REGION 2017-2025($ MILLION)
TABLE 10 GLOBAL CANCER MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 11 GLOBAL IMMUNOLOGY MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 12 GLOBAL NEUROLOGY MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 13 GLOBAL STEM CELLS MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 14 GLOBAL OTHER RESEARCH APPLICATIONS MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 15 GLOBAL SINGLE CELL ANALYSIS MARKET BY TECHNIQUE 2017-2025($ MILLION)
TABLE 16 GLOBAL FLOW CYTOMETRY MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 17 GLOBAL MASS SPECTROMETRY MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 18 GLOBAL MICROSCOPY MARKET 2017-2025($ MILLION)
TABLE 19 GLOBAL MICROSCOPY MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 20 GLOBAL NEXT GENERATION SEQUENCING MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 21 GLOBAL PCR MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 22 GLOBAL OTHER TECHNIQUES MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 23 GLOBAL SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2017-2025($ MILLION)
TABLE 24 GLOBAL ANIMAL CELL MARKET BY REGION 2017-2025( $ MILLION)
TABLE 25 GLOBAL HUMAN CELL MARKET 2017-2025( $ MILLION)
TABLE 26 GLOBAL MICROBIAL CELL MARKET 2017-2025( $ MILLION)
TABLE 27 GLOBAL BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
TABLE 28 GLOBAL CELL BANKS AND IVF CENTERS MARKET 2017-2025($ MILLION)
TABLE 29 GLOBAL HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 30 GLOBAL RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 31 GLOBAL SINGLE CELL ANALYSIS MARKET BY PRODUCTS 2017-2025($ MILLION)
TABLE 32 GLOBAL SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 33 GLOBAL SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
TABLE 34 GLOBAL SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
TABLE 35 GLOBAL SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
TABLE 36 GLOBAL SINGLE CELL ANALYSIS MARKET BY REAGENTS 2017-2025($ MILLION)
TABLE 37 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
TABLE 38 GLOBAL SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 39 GLOBAL SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
TABLE 40 GLOBAL SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
TABLE 41 GLOBAL SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
TABLE 42 GLOBAL SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
TABLE 43 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
TABLE 44 NORTH AMERICA SINGLE CELL ANALYSIS MARKET BY COUNTRIES 2017-2025($ MILLION )
TABLE 45 EUROPE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
TABLE 46 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
TABLE 47 ROW SINGLE CELL ANALYSIS MARKET BY REGIONS 2017-2025($ MILLION)
FIGURE LIST
FIGURE 1 GLOBAL SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 2 ESTIMATED NO. OF NEW CANCER CASES AND DEATHS IN U.S. IN 2016
FIGURE 3 MARKET BREAKUP BY REVENUE IN 2016
FIGURE 4 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 5 GLOBAL SINGLE CELL ANALYSIS MARKET BY CTCS 2017-2025($ MILLION)
FIGURE 6 GLOBAL SINGLE CELL ANALYSIS MARKET BY NIPT 2017-2025($ MILLION)
FIGURE 7 GLOBAL SINGLE CELL ANALYSIS MARKET BY IVF 2017-2025($ MILLION)
FIGURE 8 GLOBAL SINGLE CELL ANALYSIS MARKET BY CANCER 2017-2025($ MILLION)
FIGURE 9 GLOBAL SINGLE CELL ANALYSIS MARKET BY IMMUNOLOGY 2017-2025($ MILLION)
FIGURE 10 GLOBAL SINGLE CELL ANALYSIS MARKET BY NEUROLOGY 2017-2025($ MILLION)
FIGURE 11 GLOBAL SINGLE CELL ANALYSIS MARKET BY STEM CELLS 2017-2025($ MILLION)
FIGURE 12 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER RESEARCH APPLICATIONS 2017-2025($ MILLION)
FIGURE 13 GLOBAL SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 14 GLOBAL SINGLE CELL ANALYSIS MARKET BY MASS SPECTROMETRY 2017-2025($ MILLION)
FIGURE 15 GLOBAL SINGLE CELL ANALYSIS MARKET BY MICROSCOPY 2017-2025($ MILLION)
FIGURE 16 GLOBAL SINGLE CELL ANALYSIS MARKET BY NEXT GENERATION SEQUENCING 2017-2025($ MILLION)
FIGURE 17 GLOBAL SINGLE CELL ANALYSIS MARKET BY PCR 2017-2025($ MILLION)
FIGURE 18 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER TECHNIQUES 2017-2025($ MILLION)
FIGURE 19 GLOBAL ANIMAL CELL MARKET 2017-2025($ MILLION)
FIGURE 20 GLOBAL HUMAN CELL MARKET 2017-2025($ MILLION)
FIGURE 21 GLOBAL NEW CANCER CASES AND MOTILITY RATE IN MILLION (2015-2030)
FIGURE 22 GLOBAL MICROBIAL CELL MARKET 2017-2025($ MILLION)
FIGURE 23 GLOBAL BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
FIGURE 24 GLOBAL CELL BANKS AND IVF CENTERS MARKET
FIGURE 25 GLOBAL HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 26 GLOBAL RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 27 GLOBAL SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
FIGURE 28 GLOBAL SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
FIGURE 29 GLOBAL SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
FIGURE 30 GLOBAL SINGLE CELL ANALYSIS MARKET BY REGENTS 2017-2025($ MILLION)
FIGURE 31 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
FIGURE 32 GLOBAL SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
FIGURE 33 GLOBAL SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
FIGURE 34 GLOBAL SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 35 GLOBAL SINGLE CELL ANALYSIS MARKET BY HCS SYSTEM 2017-2025($ MILLION)
FIGURE 36 GLOBAL SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
FIGURE 37 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
FIGURE 38 REVENUE OF DIAGNOSTIC & MEDICAL LABORATORIES IN THE US, 2014-16 (BILLIONS)
FIGURE 39 US SINGLE CELL ANALYSIS MARKET
FIGURE 40 CANADA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 41 NUMBER OF PEOPLE LIVING WITH HIV IN 2015 GLOBALLY (MILLIONS)
FIGURE 42 UNITED KINGDOM SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 43 ESTIMATED WHO REGIONAL TB STATISTICS FOR 2015
FIGURE 44 FRANCE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 45 GERMANY SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 46 PERCENTAGE OF PEOPLE OVER 65 YEARS OF AGE (SPAIN)
FIGURE 47 SPAIN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 48 ITALY SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 49 ROE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 50 HEALTH REPORT OF INDIA ACCORDING 2015 SCENARIO
FIGURE 51 INDIAN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 52 NUMBER OF CASES OF LUNG CANCERSTATISTICS IN CHINA (2010-2015)
FIGURE 53 CHINA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 54 JAPAN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 55 ESTIMATED TB INCIDENCE BY AGE AND SEX (THOUSANDS), 2015 (AUSTRALIA)
FIGURE 56 AUSTRALIA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 57 RO APAC SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 58 LATIN AMERICA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 59 MENA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 60 AFRICA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 61 MARKET SHARE OF ANALYSIS OF KEY PLAYERS 2016 (%)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
4. MARKET OVERVIEW
4.1. DRIVERS
4.1.1. EXPANDING TECHNOLOGICAL INNOVATIONS
4.1.2. EXPANDING OCCURRENCE OF TRANSMITTABLE INFECTIONS ACROSS THE GLOBE
4.1.3. GROWING AGED POPULACE
4.1.4. GROWING BIOPHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
4.1.5. RISING GOVERNMENT SUBSIDY FOR RESEARCH
4.2. RESTRAINTS
4.2.1. LARGE PRIMARY COST DISCOURAGING INVESTMENT
4.2.2. CONCERNS ASSOCIATED WITH INTELLECTUAL PROPERTY AND PATENTS RIGHTS
4.3. MARKET OPPORTUNITY
4.3.1. SINGLE-CELL SEQUENCING (SCS) PROCESS BEING INCREASINGLY USED IN DNA AND RNA ANALYSIS
4.3.2. DEVELOPMENT OF INNOVATIVE MODALITIES
4.3.3. INCREASING USAGE OF MICRO FLUID SINGLE CELL TECHNIQUES
4.3.4. INCREASING INVESTMENT MADE BY THE ASIAN COUNTRIES
4.3.5. ENHANCE OPPORTUNITY IN CANCER CELL RESEARCH
4.4. CHALLENGES
4.4.1. LACK OF ADEQUATE INFRASTRUCTURE
4.4.2. DELAYED ADOPTION OF SINGLE CELL TECHNOLOGY
5. MARKET SEGMENTATION
5.1. BY APPLICATION
5.1.1. MEDICAL APPLICATIONS MARKET
5.1.1.1. CIRCULAR TUMOUR CELLS (CTCS) MARKET
5.1.1.2. NON-INVASIVE PRENATAL DIAGNOSIS MARKET
5.1.1.3. IN VITRO FERTILIZATION (IVF) MARKET
5.1.2. RESEARCH APPLICATIONS MARKET
5.1.2.1. CANCER MARKET
5.1.2.2. IMMUNOLOGY MARKET
5.1.2.3. NEUROLOGY MARKET
5.1.2.4. STEM CELLS MARKET OTHER RESEARCH APPLICATIONS MARKET
5.2. BY TECHNIQUE
5.2.1. FLOW CYTOMETRY MARKET
5.2.2. MASS SPECTROMETRY MARKET
5.2.3. MICROSCOPY MARKET
5.2.3.1. NEXT-GENERATION SEQUENCING (NGS) MARKET
5.2.3.2. PCR (POLYMERASE CHAIN REACTION) MARKET
5.2.3.3. OTHER TECHNIQUES MARKET
5.3. BY CELL TYPE
5.3.1. ANIMAL CELLS MARKET
5.3.2. HUMAN CELLS MARKET
5.3.3. MICROBIAL CELLS MARKET
5.4. BY END USER
5.4.1. BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET
5.4.2. CELL BANKS AND IVF CENTERS MARKET
5.4.3. HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET
5.4.4. RESEARCH & ACADEMIC LABORATORIES MARKET
5.5. BY PRODUCT
5.5.1. CONSUMABLE MARKET
5.5.1.1. ASSAY KITS MARKET
5.5.1.2. BEADS MARKET
5.5.1.3. MICROPLATES MARKET
5.5.1.4. REAGENTS MARKET
5.5.1.5. OTHER CONSUMABLES MARKET
5.5.2. INSTRUMENT MARKET
5.5.2.1. CELL COUNTER MARKET
5.5.2.2. CELL MICROARRAYS MARKET
5.5.2.3. FLOW CYTOMETERS MARKET
5.5.2.4. HCS SYSTEMS MARKET
5.5.2.5. MICROSCOPES
5.5.2.6. OTHER INSTRUMENTS
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCT
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.4.4. APPLICATION AND EFFECTIVENESS
6.5. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. NORTH AMERICA SINGLE CELL ANALYSIS MARKET
7.1.1. UNITED STATES (U.S.) SINGLE CELL ANALYSIS MARKET
7.1.2. CANADA SINGLE CELL ANALYSIS MARKET
7.2. EUROPE SINGLE CELL ANALYSIS MARKET
7.2.1. UNITED KINGDOM (UK) SINGLE CELL ANALYSIS MARKET
7.2.2. FRANCE SINGLE CELL ANALYSIS MARKET
7.2.3. GERMANY SINGLE CELL ANALYSIS MARKET
7.2.4. SPAIN SINGLE CELL ANALYSIS MARKET
7.2.5. ITALY SINGLE CELL ANALYSIS MARKET
7.2.6. ROE SINGLE CELL ANALYSIS MARKET
7.3. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET
7.3.1. INDIA SINGLE CELL ANALYSIS MARKET
7.3.2. CHINA SINGLE CELL ANALYSIS MARKET
7.3.3. JAPAN SINGLE CELL ANALYSIS MARKET
7.3.4. AUSTRALIA SINGLE CELL ANALYSIS MARKET
7.3.5. ROAPAC SINGLE CELL ANALYSIS MARKET
7.4. REST OF THE WORLD (ROW) SINGLE CELL ANALYSIS MARKET
7.4.1. LATIN AMERICA SINGLE CELL ANALYSIS MARKET
7.4.2. MENA SINGLE CELL ANALYSIS MARKET
7.4.3. AFRICA SINGLE CELL ANALYSIS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. TOP WINNING STRATEGIES
9. COMPANY PROFILES
9.1. CORNING INC.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC ANALYSIS
9.2. CELGENE CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVE
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. ILLUMINA INC.
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVE
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. MILTENYI BIOTEC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT ANALYSIS
9.4.5. STRATEGIC ANALYSIS
9.5. NANOSTRING TECHNOLOGIESINC
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVE
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. AGILENT TECHNOLOGY INC
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVE
9.6.4. SCOT ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. GE HEALTHCARE
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. BECKMAN COULTER, INC.
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. SCOT ANALYSIS
9.8.4. STRATEGIC ANALYSIS
9.9. MEDTRONIC’S PLC
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVE
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. STRYKER CORPORATION
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.10.4. STRATEGIC ANALYSIS
9.11. THERMO FISHER SCIENTIFIC, INC.
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVE
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. QIAGEN N V
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT ANALYSIS
9.12.4. STRATEGIC ANALYSIS
9.13. BECKTON DICKINSON AND COMPANY
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. SCOT ANALYSIS
9.13.4. STRATEGIC ANALYSIS
9.14. STEMCELL TECHNOLOGIES
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. STRATEGIC INITIATIVES
9.14.4. SCOT ANALYSIS
9.14.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 GLOBAL SINGLE ANALYSIS MARKET BY GEOGRAPHY 2014-2022($ MILLION)
TABLE 2 GLOBAL SUMMARY OF AIDS EPIDEMIC 2016
TABLE 3 GLOBAL SINGLE CELL ANALYSIS MARKET BY APPLICATION 2017-2025($ MILLION)
TABLE 4 GLOBAL SINGLE CELL ANALYSIS MARKET BY MEDICAL APPLICATIONS 2017-2025($ MILLION)
TABLE 5 GLOBAL CTCS MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 6 GLOBAL NIPT MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 7 GLOBAL IVF MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 8 GLOBAL SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS, BY REGION 2017-2025($ MILLION)
TABLE 9 GLOBAL SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS, BY REGION 2017-2025($ MILLION)
TABLE 10 GLOBAL CANCER MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 11 GLOBAL IMMUNOLOGY MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 12 GLOBAL NEUROLOGY MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 13 GLOBAL STEM CELLS MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 14 GLOBAL OTHER RESEARCH APPLICATIONS MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 15 GLOBAL SINGLE CELL ANALYSIS MARKET BY TECHNIQUE 2017-2025($ MILLION)
TABLE 16 GLOBAL FLOW CYTOMETRY MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 17 GLOBAL MASS SPECTROMETRY MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 18 GLOBAL MICROSCOPY MARKET 2017-2025($ MILLION)
TABLE 19 GLOBAL MICROSCOPY MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 20 GLOBAL NEXT GENERATION SEQUENCING MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 21 GLOBAL PCR MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 22 GLOBAL OTHER TECHNIQUES MARKET BY GEOGRAPHY 2017-2025($ MILLION)
TABLE 23 GLOBAL SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2017-2025($ MILLION)
TABLE 24 GLOBAL ANIMAL CELL MARKET BY REGION 2017-2025( $ MILLION)
TABLE 25 GLOBAL HUMAN CELL MARKET 2017-2025( $ MILLION)
TABLE 26 GLOBAL MICROBIAL CELL MARKET 2017-2025( $ MILLION)
TABLE 27 GLOBAL BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
TABLE 28 GLOBAL CELL BANKS AND IVF CENTERS MARKET 2017-2025($ MILLION)
TABLE 29 GLOBAL HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 30 GLOBAL RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 31 GLOBAL SINGLE CELL ANALYSIS MARKET BY PRODUCTS 2017-2025($ MILLION)
TABLE 32 GLOBAL SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 33 GLOBAL SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
TABLE 34 GLOBAL SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
TABLE 35 GLOBAL SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
TABLE 36 GLOBAL SINGLE CELL ANALYSIS MARKET BY REAGENTS 2017-2025($ MILLION)
TABLE 37 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
TABLE 38 GLOBAL SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 39 GLOBAL SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
TABLE 40 GLOBAL SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
TABLE 41 GLOBAL SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
TABLE 42 GLOBAL SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
TABLE 43 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
TABLE 44 NORTH AMERICA SINGLE CELL ANALYSIS MARKET BY COUNTRIES 2017-2025($ MILLION )
TABLE 45 EUROPE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
TABLE 46 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
TABLE 47 ROW SINGLE CELL ANALYSIS MARKET BY REGIONS 2017-2025($ MILLION)
FIGURE LIST
FIGURE 1 GLOBAL SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 2 ESTIMATED NO. OF NEW CANCER CASES AND DEATHS IN U.S. IN 2016
FIGURE 3 MARKET BREAKUP BY REVENUE IN 2016
FIGURE 4 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 5 GLOBAL SINGLE CELL ANALYSIS MARKET BY CTCS 2017-2025($ MILLION)
FIGURE 6 GLOBAL SINGLE CELL ANALYSIS MARKET BY NIPT 2017-2025($ MILLION)
FIGURE 7 GLOBAL SINGLE CELL ANALYSIS MARKET BY IVF 2017-2025($ MILLION)
FIGURE 8 GLOBAL SINGLE CELL ANALYSIS MARKET BY CANCER 2017-2025($ MILLION)
FIGURE 9 GLOBAL SINGLE CELL ANALYSIS MARKET BY IMMUNOLOGY 2017-2025($ MILLION)
FIGURE 10 GLOBAL SINGLE CELL ANALYSIS MARKET BY NEUROLOGY 2017-2025($ MILLION)
FIGURE 11 GLOBAL SINGLE CELL ANALYSIS MARKET BY STEM CELLS 2017-2025($ MILLION)
FIGURE 12 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER RESEARCH APPLICATIONS 2017-2025($ MILLION)
FIGURE 13 GLOBAL SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 14 GLOBAL SINGLE CELL ANALYSIS MARKET BY MASS SPECTROMETRY 2017-2025($ MILLION)
FIGURE 15 GLOBAL SINGLE CELL ANALYSIS MARKET BY MICROSCOPY 2017-2025($ MILLION)
FIGURE 16 GLOBAL SINGLE CELL ANALYSIS MARKET BY NEXT GENERATION SEQUENCING 2017-2025($ MILLION)
FIGURE 17 GLOBAL SINGLE CELL ANALYSIS MARKET BY PCR 2017-2025($ MILLION)
FIGURE 18 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER TECHNIQUES 2017-2025($ MILLION)
FIGURE 19 GLOBAL ANIMAL CELL MARKET 2017-2025($ MILLION)
FIGURE 20 GLOBAL HUMAN CELL MARKET 2017-2025($ MILLION)
FIGURE 21 GLOBAL NEW CANCER CASES AND MOTILITY RATE IN MILLION (2015-2030)
FIGURE 22 GLOBAL MICROBIAL CELL MARKET 2017-2025($ MILLION)
FIGURE 23 GLOBAL BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
FIGURE 24 GLOBAL CELL BANKS AND IVF CENTERS MARKET
FIGURE 25 GLOBAL HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 26 GLOBAL RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 27 GLOBAL SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
FIGURE 28 GLOBAL SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
FIGURE 29 GLOBAL SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
FIGURE 30 GLOBAL SINGLE CELL ANALYSIS MARKET BY REGENTS 2017-2025($ MILLION)
FIGURE 31 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
FIGURE 32 GLOBAL SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
FIGURE 33 GLOBAL SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
FIGURE 34 GLOBAL SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 35 GLOBAL SINGLE CELL ANALYSIS MARKET BY HCS SYSTEM 2017-2025($ MILLION)
FIGURE 36 GLOBAL SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
FIGURE 37 GLOBAL SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
FIGURE 38 REVENUE OF DIAGNOSTIC & MEDICAL LABORATORIES IN THE US, 2014-16 (BILLIONS)
FIGURE 39 US SINGLE CELL ANALYSIS MARKET
FIGURE 40 CANADA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 41 NUMBER OF PEOPLE LIVING WITH HIV IN 2015 GLOBALLY (MILLIONS)
FIGURE 42 UNITED KINGDOM SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 43 ESTIMATED WHO REGIONAL TB STATISTICS FOR 2015
FIGURE 44 FRANCE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 45 GERMANY SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 46 PERCENTAGE OF PEOPLE OVER 65 YEARS OF AGE (SPAIN)
FIGURE 47 SPAIN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 48 ITALY SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 49 ROE SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 50 HEALTH REPORT OF INDIA ACCORDING 2015 SCENARIO
FIGURE 51 INDIAN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 52 NUMBER OF CASES OF LUNG CANCERSTATISTICS IN CHINA (2010-2015)
FIGURE 53 CHINA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 54 JAPAN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 55 ESTIMATED TB INCIDENCE BY AGE AND SEX (THOUSANDS), 2015 (AUSTRALIA)
FIGURE 56 AUSTRALIA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 57 RO APAC SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 58 LATIN AMERICA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 59 MENA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 60 AFRICA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 61 MARKET SHARE OF ANALYSIS OF KEY PLAYERS 2016 (%)
